PROTECTIVE EFFECT OF VITAMIN-D3 ANALOGS ON ENDOTOXIN-SHOCK IN MICE

被引:33
作者
HORIUCHI, H [1 ]
NAGATA, I [1 ]
KOMORIYA, K [1 ]
机构
[1] TEIJIN INST BIOMED RES 2,PHARMACOL RES DEPT,ASAHIGAOKA 4-3-2,HINO,TOKYO 191,JAPAN
来源
AGENTS AND ACTIONS | 1991年 / 33卷 / 3-4期
关键词
D O I
10.1007/BF01986584
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The effect of vitamin D3 analogues on endotoxin shock in mice was investigated. Male ICR mice were orally administered vitamin D3 analogues or vehicle, accompanied by an intraperitoneal injection of endotoxin (E. Coli lipopolysaccharide, LPS, 20 mg/kg). Endotoxin caused a decrease in survival rate in a time-dependent manner. Increases in plasma immunoreactive (i) eicosanoid and hepatic malondialdehyde (MDA) levels were also observed. Administration of 1-alpha-hydroxyvitamin D3 (1-alpha-OH-D3) improved the survival rate 24 to 48 h after endotoxin treatment. The effects were markedly observed at a dose of 20 ng/kg. In addition, 1-alpha-OH-D3 restored the plasma iTXB2 and hepatic MDA levels 8 h after endotoxin injection. However, it did not affect plasma iPGE2, i6-keto-PGF1-alpha and blood iLTB4 levels. At a dose of 20 ng/kg, both 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) and 1,24(R)-dihydroxyvitamin D3 (1,24(R)-(OH)2D3) restored the survival rate, the plasma iTXB2 and hepatic MDA levels. These results suggest that vitamin D3 analogues may inhibit endotoxemia through regulation of the formation of TXA2 and free radicals.
引用
收藏
页码:343 / 348
页数:6
相关论文
共 32 条
[1]   DIFFERENTIATION OF MOUSE MYELOID-LEUKEMIA CELLS INDUCED BY 1-ALPHA,25-DIHYDROXYVITAMIN-D3 [J].
ABE, E ;
MIYAURA, C ;
SAKAGAMI, H ;
TAKEDA, M ;
KONNO, K ;
YAMAZAKI, T ;
YOSHIKI, S ;
SUDA, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (08) :4990-4994
[2]   1-ALPHA,25-DIHYDROXYVITAMIN-D3 INDUCES MATURATION OF THE HUMAN MONOCYTE CELL-LINE U937, AND, IN ASSOCIATION WITH A FACTOR FROM HUMAN LYMPHOCYTES-T, AUGMENTS PRODUCTION OF THE MONOKINE, MONONUCLEAR CELL FACTOR [J].
AMENTO, EP ;
BHALLA, AK ;
KURNICK, JT ;
KRADIN, RL ;
CLEMENS, TL ;
HOLICK, SA ;
HOLICK, MF ;
KRANE, SM .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 73 (03) :731-739
[3]   ROLES FOR THROMBOXANE-A-2 AND LEUKOTRIENES IN ENDOTOXIN INDUCED ACUTE-RENAL-FAILURE [J].
BADR, KF ;
KELLEY, VE ;
RENNKE, HG ;
BRENNER, BM .
KIDNEY INTERNATIONAL, 1986, 30 (04) :474-480
[4]   DIFFERENTIAL-EFFECTS OF 1,25-DIHYDROXYVITAMIN D3 ON HUMAN-LYMPHOCYTES AND MONOCYTE MACROPHAGES - INHIBITION OF INTERLEUKIN-2 AND AUGMENTATION OF INTERLEUKIN-1 PRODUCTION [J].
BHALLA, AK ;
AMENTO, EP ;
KRANE, SM .
CELLULAR IMMUNOLOGY, 1986, 98 (02) :311-322
[5]  
BOTTOMS GD, 1985, CIRC SHOCK, V15, P155
[6]  
COHEN MS, 1986, J IMMUNOL, V136, P1049
[7]  
ETEMADI AR, 1987, CIRC SHOCK, V22, P55
[8]   METABOLISM OF 1ALPHA-HYDROXYVITAMIN-D3 TO 1ALPHA,25-DIHYDROXYVITAMIN-D3 IN PERFUSED RAT-LIVER [J].
FUKUSHIMA, M ;
SUZUKI, Y ;
TOHIRA, Y ;
MATSUNAGA, I ;
OCHI, K ;
NAGANO, H ;
NISHII, Y ;
SUDA, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1975, 66 (02) :632-638
[9]  
HAGMANN W, 1984, CIRC SHOCK, V14, P223
[10]   SYNTHESIS OF [6-H-3]-1-ALPHA-HYDROXYVITAMIN-D3 AND ITS METABOLISM INVIVO TO [H-3]-1-ALPHA,25-DIHYDROXYVITAMIN-D3 [J].
HOLICK, MF ;
HOLICK, SA ;
TAVELA, T ;
GALLAGHER, B ;
SCHNOES, HK ;
DELUCA, HF .
SCIENCE, 1975, 190 (4214) :576-578